Cornea

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers

Farhad Hafezi, FARVO, MD, PhD, and colleagues reported on results achieved with phototherapeutic keratectomy-assisted, customised, epi-on corneal crosslinking

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting

Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease

Current and future options for Fuchs endothelial corneal dystrophy

Neltependocel has received both regulatory and reimbursement approval in Japan

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress

Phase 1 multicentre study data demonstrate early signs of efficacy

Akantior, an anti-amoebic polymer eye drop, is the first and only authorised medical product for the treatment of AK in the world, according to a news release.

European patients navigate new therapies and market change-ups

Specular microscopy showed "long-term alterations" in corneal cells

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

Educational resources include handouts, videos and a dedicated webpage on the proper way to use eye drops

The adaptor was tested by low-vision patients and participants with simulated visual impairment

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

Challenging choices force ophthalmologists to weigh long-term outcomes

Inhibiting ferroptosis could be crucial to reducing inflammation

At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology

Astigmatic values differed between K and TK readings

Elias Kahan speaks about his ARVO poster, "Contact specular microscopy reliably images the same location of the corneal epithelium"

At this year's ARVO meeting, Neda Gioia, OD, discussed the increasing patient burden of dry eye disease

Eric Donnenfeld, MD, discusses the clinical evaluation of Blink Triple Care artificial tears ahead of the 2024 ARVO meeting